IGF1 and melanoma: To investigate the clinical significance of IGF-1 and TAB cells, we analyzed TCGA-SKCM melanoma data (n = 473) and observed a heterogeneous expression of B-cell signature genes (Supplementary Table 1; Supplementary Fig. 2a) and IGF1 (Supplementary Fig. 2a) between tumor samples.